GL1X · GenesisL1 explorer

MolNFT v1 · #161501 · protein

Structure of human BCL-2 in complex with analogue of abt-737

6QGG · Apoptosis regulator BCL-2,BCL-2-like protein 1,APOPTOSIS…: “Structure of human BCL-2 in complex with analogue of abt-737”. X-ray diffraction, 1 ligand (J1H), 1 pocket (best druggability 0.45). MolNFT v1 #161501 on GenesisL1: 3D…

PDB
6QGG
Type
protein
Length
140 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Apoptosis regulator BCL-2,BCL-2-like protein 1,APOPTOSIS regulator BCL-2,BCL-2-like…
UniProt
P10415, Q07817
Ligands
J1H
Pockets
1 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 76% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AApoptosis regulator BCL-2,BCL-2-like protein 1,APOPTOSIS regulator BCL-2,BCL-2-like protein 1protein14076% helix, 0% strandP10415, Q07817

Ligands and binding sites

  • J1H · [(3~{R})-3-[[4-[[4-[4-[[2-(4-chlorophenyl) phenyl]methyl]piperazin-1-yl]phenyl]carbonylsulfamoyl]-2-nitro-phenyl]amino]-4-phenylsulfanyl-butyl]-(2-hydroxy-2-oxoethyl)-dimethyl-azanium · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11000.450.7814empty

Compared structures

  • 6QGG · Structure of human Bcl-2 in complex with analogue of ABT-737 · the same entry in another collection · chain A against A, TM-score 1.00
  • P10415 · AlphaFold monomer V2.0 prediction for apoptosis regulator BCL-2 (P10415) · a predicted model of the same protein · chain A against A, TM-score 0.97
  • Q07817 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 1 (Q07817) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.